MedicineBiology

N. Ferrara, H. Gerber

2002.1.24ACTA HAEMATOLOGICA

DOI: 10.1159/000046610

tlooto Summary

Clinical trials are ongoing to test the hypothesis that inhibition of VEGF activity may be beneficial for these conditions, including tumors and intraocular neovascular syndromes.

Abstract

Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen and an angiogenic inducer as well as a mediator of vascular permeability. The biological effects of VEGF are mediated by two tyrosine kinase receptors, Flt-1 (VEGFr-1) and KDR (VEGFR-2). VEGF is essential for developmental angiogenesis and is also required for female reproductive functions and endochondral bone formation. Substantial evidence also implicates VEGF in tumors and intraocular neovascular syndromes. Currently, several clinical trials are ongoing to test the hypothesis that inhibition of VEGF activity may be beneficial for these conditions.

Citation format

FERRARA, N.; GERBER, H. The role of vascular endothelial growth factor in angiogenesis. ACTA HAEMATOLOGICA, 2002, 106: 148–156.